Rabu, 23 April 2008
ALUMINIUM CHLORHYDRAAT DALAM DEODORANTS
Aluminium Chlorhydraat, untuk selanjutnya saya singkat menjadi AC.
AC terdapat dalam Nivea Deodorant sensitive without alcohol dan juga dalam
Dove Deodorant Silk Dry (tutup emas), tidak didalam Dove fresh touch.
Baru2 ini saya menghadiri sebuah seminar tentang kanker payudara. Waktu
session tanya-jawab, saya mengajukan pertanyaan ttg. mengapa bagian ketiak
adalah tempat dimana paling sering perkembangan kanker payudara terjadi.
Waktu itu pertanyaan saya tidak bisa dijawab. Selang beberapa waktu, saya
menerima pos, dimana ada keterangan/jawaban atas pertanyaan saya tsb.
diatas. Keterangan atau jawaban tsb. ingin saya informasikan kepada anda
semua.
Penyebab utama untuk kanker payudara adalah karena pemakaian produk2
ANTI-TRANSPIRANTEN (= anti keringat).
Kebanyakan produk yang ada dipasaran merupakan kombinasi dari anti-keringat
dan deodorant.
Produk Deodorant sendiri tidak berbahaya.
Mohon periksa bahan2 apa saja yang tertera dikemasan produk2 deodorant
anti-keringat anda dirumah! Bila mereka mengandung AC, SEGERA BUANGLAH,
a.l. Rexona dan Dove Deodorant.
Coba menggunakan merk2 lain yang tidak mengandung bahan AC ini.
Alasannya adalah sederhana:
Hanya beberapa bagian dari tubuh kita yang dapat mengeleminasi zat2 racun,
yaitu bag. belakang lutut, belakang kuping, diantara kaki dan ketiak. Zat2
racun ini dikeluarkan dalam bentuk keringat.
Produk2 anti-keringat mencegah keringat keluar. Dengan menggunakan
deodorant anti-keringat, zat2 racun tadi tidak bisa dikeluarkan dari dalam
tubuh, melainkan tertumpuk di kelenjar getah bening dibawah lengan.
Asal kanker payudara kebanyakan ditemukan di area bagian atas payudara.
Laki2 tidak sepeka wanita terhadap type penyakit ini. Meskipun laki2
menggunakan produk2 anti-keringat, bahan2 produk ini biasanya tinggal
melekat dipermukaan ketiak dan tidak langsung masuk kedalam kulit.
Kaum wanita yang setelah mencukur rambut ketiak langsung menggunakan produk
anti-keringat lebih banyak risikonya, karena lewat luka2 kecil yg mungkin
terjadi akibat mencukur rambut ketiak tsb., bahan2 kimia yang ada dalam
produk anti-keringat bisa lebih cepat masuk kedalam tubuh.
AC terdapat dalam Nivea Deodorant sensitive without alcohol dan juga dalam
Dove Deodorant Silk Dry (tutup emas), tidak didalam Dove fresh touch.
Baru2 ini saya menghadiri sebuah seminar tentang kanker payudara. Waktu
session tanya-jawab, saya mengajukan pertanyaan ttg. mengapa bagian ketiak
adalah tempat dimana paling sering perkembangan kanker payudara terjadi.
Waktu itu pertanyaan saya tidak bisa dijawab. Selang beberapa waktu, saya
menerima pos, dimana ada keterangan/jawaban atas pertanyaan saya tsb.
diatas. Keterangan atau jawaban tsb. ingin saya informasikan kepada anda
semua.
Penyebab utama untuk kanker payudara adalah karena pemakaian produk2
ANTI-TRANSPIRANTEN (= anti keringat).
Kebanyakan produk yang ada dipasaran merupakan kombinasi dari anti-keringat
dan deodorant.
Produk Deodorant sendiri tidak berbahaya.
Mohon periksa bahan2 apa saja yang tertera dikemasan produk2 deodorant
anti-keringat anda dirumah! Bila mereka mengandung AC, SEGERA BUANGLAH,
a.l. Rexona dan Dove Deodorant.
Coba menggunakan merk2 lain yang tidak mengandung bahan AC ini.
Alasannya adalah sederhana:
Hanya beberapa bagian dari tubuh kita yang dapat mengeleminasi zat2 racun,
yaitu bag. belakang lutut, belakang kuping, diantara kaki dan ketiak. Zat2
racun ini dikeluarkan dalam bentuk keringat.
Produk2 anti-keringat mencegah keringat keluar. Dengan menggunakan
deodorant anti-keringat, zat2 racun tadi tidak bisa dikeluarkan dari dalam
tubuh, melainkan tertumpuk di kelenjar getah bening dibawah lengan.
Asal kanker payudara kebanyakan ditemukan di area bagian atas payudara.
Laki2 tidak sepeka wanita terhadap type penyakit ini. Meskipun laki2
menggunakan produk2 anti-keringat, bahan2 produk ini biasanya tinggal
melekat dipermukaan ketiak dan tidak langsung masuk kedalam kulit.
Kaum wanita yang setelah mencukur rambut ketiak langsung menggunakan produk
anti-keringat lebih banyak risikonya, karena lewat luka2 kecil yg mungkin
terjadi akibat mencukur rambut ketiak tsb., bahan2 kimia yang ada dalam
produk anti-keringat bisa lebih cepat masuk kedalam tubuh.
Kamis, 10 April 2008
HIV Infection and AIDS, An Overview
AIDS - acquired immunodeficiency syndrome - was first reported in the United States in 1981 and has since become a major worldwide epidemic. AIDS is caused by the human immunodeficiency virus (HIV). By killing or damaging cells of the body's immune system, HIV progressively destroys the body's ability to fight infections and certain cancers. People diagnosed with AIDS may get life-threatening diseases called opportunistic infections, which are caused by microbes such as viruses or bacteria that usually do not make healthy people sick. More than 700,000 cases of AIDS have been reported in the United States since 1981, and as many as 900,000 Americans may be infected with HIV. The epidemic is growing most rapidly among minority populations and is a leading killer of African-American males. According to the U.S. Centers for Disease Control and Prevention (CDC), AIDS affects nearly seven times more African Americans than whites and three times more Hispanics than whites (CDC HIV/AIDS Surveillance Report, Vol. 12, 2000).
How is HIV transmitted?HIV is spread most commonly by having unprotected sex with an infected partner. The virus can enter the body through the lining of the vagina, vulva, penis, rectum, or mouth during sex. HIV also is spread through contact with infected blood. Before donated blood was screened for evidence of HIV infection and before heat-treating techniques to destroy HIV in blood products were introduced, HIV was transmitted through transfusions of contaminated blood or blood components. Today, because of blood screening and heat treatment, the risk of getting HIV from such transfusions is extremely small. HIV frequently is spread among injection drug users by the sharing of needles or syringes contaminated with very small quantities of blood from someone infected with the virus. It is rare, however, for a patient to give HIV to a health care worker or vice-versa by accidental sticks with contaminated needles or other medical instruments. Women can transmit HIV to their babies during pregnancy or birth. Approximately one-quarter to one-third of all untreated pregnant women infected with HIV will pass the infection to their babies. HIV also can be spread to babies through the breast milk of mothers infected with the virus. If the mother takes the drug AZT during pregnancy, she can reduce significantly the chances that her baby will get be infected with HIV. If health care providers treat mothers with AZT and deliver their babies by cesarean section, the chances of the baby being infected can be reduced to a rate of 1 percent. A study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) in Uganda found a highly effective and safe drug regimen for preventing transmission of HIV from an infected mother to her newborn that is more affordable and practical than any other examined to date. Interim results from the study show that a single oral dose of the antiretroviral drug nevirapine (NVP) given to an HIV-infected woman in labor and another to her baby within three days of birth reduces the transmission rate by half compared with a similar short course of AZT. Although researchers have found HIV in the saliva of infected people, there is no evidence that the virus is spread by contact with saliva. Laboratory studies reveal that saliva has natural properties that limit the power of HIV to infect. Research studies of people infected with HIV have found no evidence that the virus is spread to others through saliva by kissing. No one knows, however, whether so-called "deep" kissing, involving the exchange of large amounts of saliva, or oral intercourse increase the risk of infection. Scientists also have found no evidence that HIV is spread through sweat, tears, urine, or feces. Studies of families of HIV-infected people have shown clearly that HIV is not spread through casual contact such as the sharing of food utensils, towels and bedding, swimming pools, telephones, or toilet seats. HIV is not spread by biting insects such as mosquitoes or bedbugs. HIV can infect anyone who practices risky behaviors such as
sharing drug needles or syringes
having sexual contact with an infected person without using a condom
having sexual contact with someone whose HIV status is unknown Having a sexually transmitted disease such as syphilis, genital herpes, chlamydial infection, gonorrhea, or bacterial vaginosis appears to make people more susceptible to getting HIV infection during sex with infected partners.
How is HIV transmitted?HIV is spread most commonly by having unprotected sex with an infected partner. The virus can enter the body through the lining of the vagina, vulva, penis, rectum, or mouth during sex. HIV also is spread through contact with infected blood. Before donated blood was screened for evidence of HIV infection and before heat-treating techniques to destroy HIV in blood products were introduced, HIV was transmitted through transfusions of contaminated blood or blood components. Today, because of blood screening and heat treatment, the risk of getting HIV from such transfusions is extremely small. HIV frequently is spread among injection drug users by the sharing of needles or syringes contaminated with very small quantities of blood from someone infected with the virus. It is rare, however, for a patient to give HIV to a health care worker or vice-versa by accidental sticks with contaminated needles or other medical instruments. Women can transmit HIV to their babies during pregnancy or birth. Approximately one-quarter to one-third of all untreated pregnant women infected with HIV will pass the infection to their babies. HIV also can be spread to babies through the breast milk of mothers infected with the virus. If the mother takes the drug AZT during pregnancy, she can reduce significantly the chances that her baby will get be infected with HIV. If health care providers treat mothers with AZT and deliver their babies by cesarean section, the chances of the baby being infected can be reduced to a rate of 1 percent. A study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) in Uganda found a highly effective and safe drug regimen for preventing transmission of HIV from an infected mother to her newborn that is more affordable and practical than any other examined to date. Interim results from the study show that a single oral dose of the antiretroviral drug nevirapine (NVP) given to an HIV-infected woman in labor and another to her baby within three days of birth reduces the transmission rate by half compared with a similar short course of AZT. Although researchers have found HIV in the saliva of infected people, there is no evidence that the virus is spread by contact with saliva. Laboratory studies reveal that saliva has natural properties that limit the power of HIV to infect. Research studies of people infected with HIV have found no evidence that the virus is spread to others through saliva by kissing. No one knows, however, whether so-called "deep" kissing, involving the exchange of large amounts of saliva, or oral intercourse increase the risk of infection. Scientists also have found no evidence that HIV is spread through sweat, tears, urine, or feces. Studies of families of HIV-infected people have shown clearly that HIV is not spread through casual contact such as the sharing of food utensils, towels and bedding, swimming pools, telephones, or toilet seats. HIV is not spread by biting insects such as mosquitoes or bedbugs. HIV can infect anyone who practices risky behaviors such as
sharing drug needles or syringes
having sexual contact with an infected person without using a condom
having sexual contact with someone whose HIV status is unknown Having a sexually transmitted disease such as syphilis, genital herpes, chlamydial infection, gonorrhea, or bacterial vaginosis appears to make people more susceptible to getting HIV infection during sex with infected partners.
Improving brain cell survival after brain injury
Scientists at Melbourne's Howard Florey Institute have found a protein in the brain that can save neurons from dying after experiencing traumatic brain injury from incidents such as stroke, car accidents and falls.
The team, led by Professor Seong-Seng Tan, has discovered that this naturally occurring protein, called BP5, is produced more than usual in brain cells after they have experienced traumatic injury.
Prof Tan said that because this protein is "over-expressed", it can prevent the neuron's cells from dying, thus reducing brain damage.
"BP5's pattern of expression indicates that it allows neurons to survive in a stressed environment," Professor Tan said.
"We have tested this hypothesis in mice by expressing BP5 in stressed neurons and this proof-of-principle experiment showed that BP5 can prevent neurons from undergoing cell death.
"BP5 works by using the cell's waste disposal system to flush away toxic and damaged proteins produced after injury, which appears to tip the balance towards nerve cell survival, instead of death," he said.
Professor Tan is the first to show that this mechanism can be fruitfully manipulated to prevent brain cells from dying. For this reason, his work has been published by the Journal of Neuroscience, the peak body journal of the American Society for Neuroscience.
"Now our challenge is to understand how BP5 performs it neuron-saving function and develop drugs that can do the same thing," Professor Tan said.
"Ultimately, we want to deliver the drug to patients suffering brain injury from stroke or trauma so save as many neurons as possible.
"Such a drug would limit damage to the brain after the injury, as well as the subsequent few days when injured nerves release 'suicide factors' that cause surrounding, healthy neurons to die en masse.
The team, led by Professor Seong-Seng Tan, has discovered that this naturally occurring protein, called BP5, is produced more than usual in brain cells after they have experienced traumatic injury.
Prof Tan said that because this protein is "over-expressed", it can prevent the neuron's cells from dying, thus reducing brain damage.
"BP5's pattern of expression indicates that it allows neurons to survive in a stressed environment," Professor Tan said.
"We have tested this hypothesis in mice by expressing BP5 in stressed neurons and this proof-of-principle experiment showed that BP5 can prevent neurons from undergoing cell death.
"BP5 works by using the cell's waste disposal system to flush away toxic and damaged proteins produced after injury, which appears to tip the balance towards nerve cell survival, instead of death," he said.
Professor Tan is the first to show that this mechanism can be fruitfully manipulated to prevent brain cells from dying. For this reason, his work has been published by the Journal of Neuroscience, the peak body journal of the American Society for Neuroscience.
"Now our challenge is to understand how BP5 performs it neuron-saving function and develop drugs that can do the same thing," Professor Tan said.
"Ultimately, we want to deliver the drug to patients suffering brain injury from stroke or trauma so save as many neurons as possible.
"Such a drug would limit damage to the brain after the injury, as well as the subsequent few days when injured nerves release 'suicide factors' that cause surrounding, healthy neurons to die en masse.
Langganan:
Postingan (Atom)